Efficacy and Safety of Opicapone in Parkinson's Disease Patients According to Duration of Motor Fluctuations: Post-Hoc Analysis of BIPARK-I and II

被引：0
|
作者：
Ebersbach, G. [1 ]
Rascol, O. [1 ]
Ferreira, J. [1 ]
Costa, R. [1 ]
Rocha, J. -F. [1 ]
Magalhaes, D. [1 ]
Soares-da-Silva, P. [1 ]
机构：
[1] Beelitz Hosp, Beelitz, Germany
来源：
MOVEMENT DISORDERS | 2020年 / 35卷
关键词：
LEVODOPA; ADJUNCT;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
993
引用
收藏
页码：S444 / S444
页数：1
相关论文
共 50 条
  • [1] EFFICACY/SAFETY OF OPICAPONE IN PARKINSON'S DISEASE PATIENTS ACCORDING TO DURATION OF MOTOR FLUCTUATIONS: POST-HOC ANALYSIS OF BIPARK-I AND II
    Ebersbach, G.
    Rascol, O.
    Ferreira, J. J.
    Costa, R.
    Rocha, J. F.
    Magalhaes, D.
    Soares-da-Silva, P.
    PARKINSONISM & RELATED DISORDERS, 2020, 79 : E63 - E64
  • [2] Efficacy and safety of opicapone in Parkinson's disease patients according to duration of motor fluctuations: post-hoc analysis of BIPARK-I and II
    Ebersbach, G.
    Rascol, O.
    Ferreira, J. J.
    Costa, R.
    Rocha, J. -F.
    Magalhaes, D.
    Soares-Da-Silva, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 659 - 660
  • [3] Influence of disease duration in the efficacy response of Parkinson's disease patients with motor fluctuations: post-hoc analysis from combined BIPARK-I and II
    Gama, H.
    Ferreira, J.
    Lees, A.
    Antonini, A.
    Rascol, O.
    Santos, A.
    Magalhaes, D.
    Rocha, J.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2019, 34 : S41 - S41
  • [4] Influence of disease duration in the efficacy response of Parkinson's disease patients with motor fluctuations: Post-hoc analysis from combined BIPARK-I and II
    Santos, A.
    Ferreira, J.
    Lees, A.
    Antonini, A.
    Rascol, O.
    Gama, H.
    Magalhaes, D.
    Rocha, J.
    Soares-Da-Silva, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 656 - 656
  • [5] Efficacy of opicapone in Parkinson's disease patients according to baseline rasagiline use: a post-hoc analysis from combined BIPARK-I and II
    Lees, A.
    Ferreira, J.
    Rascol, O.
    Poewe, W.
    Tolosa, E.
    Gama, H.
    Magalhaes, D.
    Rocha, J.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2019, 34 : S57 - S57
  • [6] Efficacy of opicapone in Parkinson's disease patients according to baseline rasagiline use: A post-hoc analysis from combined BIPARK-I and II
    Lees, A.
    Ferreira, J.
    Rascol, O.
    Poewe, W.
    Tolosa, E.
    Gama, H.
    Magalhaes, D.
    Rocha, J.
    Soares-Da-Silva, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 653 - 653
  • [7] Efficacy of opicapone in Parkinson's disease patients according to baseline presence of dyskinesia: A post-hoc analysis from combined BIPARK-I and II
    Lees, A.
    Ferreira, J.
    Antonini, A.
    Reichmann, H.
    Costa, R.
    Magalhaes, D.
    Rocha, F.
    Soares-da-Silva, P.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 405
  • [8] Efficacy of opicapone in Parkinson's disease patients according to baseline pramipexole use: A post-hoc analysis from combined BIPARK-I and II
    Lees, A.
    Ferreira, J.
    Rascol, O.
    Poewe, W.
    Stocchi, F.
    Santos, A.
    Magalhaes, D.
    Rocha, F.
    Soares-da-Silva, P.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 405
  • [9] Efficacy of opicapone in Parkinson's disease patients according to baseline presence of dyskinesia: post-hoc analysis from combined BIPARK-I and II
    Lees, A.
    Ferreira, J.
    Antonini, A.
    Reichmann, H.
    Costa, R.
    Magalhaes, D.
    Rocha, J.
    Soares-Da-Silva, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 652 - 652
  • [10] Efficacy of opicapone in Parkinson's disease patients according to baseline presence of dyskinesia: a post-hoc analysis from combined BIPARK-I and II
    Lees, A.
    Ferreira, J.
    Antonini, A.
    Reichmann, H.
    Costa, R.
    Magalhaes, D.
    Rocha, J.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2019, 34 : S56 - S57
12345